510(k) Report

510(k) · Cleared

Cleared

Kilowin

K971214510(k) TraditionalCleared Jun 11, 1998435-day reviewClass II21 CFR 882.1890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cadwell Laboratories, Inc. · GWE Stimulator, Photic, Evoked Response

Cleared on Jun 11, 1998 after a 435-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 4 later devices descend from it.

Decided
Jun 11, 1998
Review
435 days
Class
Class II
Product code
GWE
Recalls
None
Predicates
0

4 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2014: 1 descendant cleared2018: 1 descendant cleared2020: 1 descendant cleared2023: 1 descendant cleared1995200020052010201520202025
  1. This deviceK971214 KilowinCadwell Laboratories, Inc. · 1998
  2. Descendant · cites it directly · 3 of its ownK133355 Cadwell Flex Eeg/PSGCadwell Industries, Inc. · 2014
  3. Descendant · 2 generations on · 2 of its ownK180269 Cadwell Apollo SystemCadwell Industries, Inc. · 2018
  4. Descendant · 3 generations on · 1 of its ownK201819 Cadwell Apollo SystemCadwell Industries, Inc. · 2020
  5. Descendant · 4 generations on · 0 of its ownK221959 Q21Neurofield, Inc. · 2023

Most influential descendants

Showing 4 of 4 · See all
  • K133355Cadwell Flex Eeg/PSGCadwell Industries, Inc. · 2014 · cites it directly3descendants
  • K180269Cadwell Apollo SystemCadwell Industries, Inc. · 2018 · 2 generations on2descendants
  • K201819Cadwell Apollo SystemCadwell Industries, Inc. · 2020 · 3 generations on1descendant
  • K221959Q21Neurofield, Inc. · 2023 · 4 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K971214KilowinCadwell Laboratories, Inc.1998—
+1K133355Cadwell Flex Eeg/PSGCadwell Industries, Inc.2014—
+2K180269Cadwell Apollo SystemCadwell Industries, Inc.2018—
+3K201819Cadwell Apollo SystemCadwell Industries, Inc.2020—
+4K221959Q21Neurofield, Inc.2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
201810
202010
202310
FIG. 1 — Lineage of K971214, 1998–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GWE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GWE device

  1. #1 K211643 Vision Monitor - MonpackONEscore 5.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (4)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K133355Cadwell Flex Eeg/PSGCadwell Industries, Inc.20143

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K133355 (Cadwell Industries, Inc., 2014) has gone furthest, with 3 descendants of its own.

How does its category compare?

All GWE devices

GWE Stimulator, Photic, Evoked Response: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GWE

2in 2022

2009: 12010: 12011: 12012: 22015: 12018: 12020: 12021: 22022: 2
2007high 2 (2012) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GWE

Too few GWE 510(k)s in any year since 2007 to give a median.

Recalls per year · GWE

1in 2015

2007: 12015: 1
2007high 1 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GWE

1in 2025

2008: 12010: 12012: 12014: 12016: 22018: 22022: 22025: 1
2007high 2 (2016) · low 0 (2007)2025

MAUDE reports naming product code GWE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—10
20080—01
20091—00
20101—01
20111—00
20122—01
20130—00
20140—01
20151—10
20160—02
20170—00
20181—02
20190—00
20201—00
20212—00
20222—02
20230—00
20240—00
20250—01
20260—0—

What is it indicated for?

Kilowin is an electroneurodiagnostic device designed to measure and display the electrical signals generated by peripheral nerve, muscle and central nervous system. It will acquire the data necessary for electroencephalography (EEG), electronystagmography (ENG), electrocardiography (ECG), electromyography (EMG), nerve conduction velocity (NCV, F wave, and H reflex), evoked potentials (EP, brainstem, visual, somatosensory), repetitive nerve stimulation…

Read the full statement (133 words)

Kilowin is an electroneurodiagnostic device designed to measure and display the electrical signals generated by peripheral nerve, muscle and central nervous system. It will acquire the data necessary for electroencephalography (EEG), electronystagmography (ENG), electrocardiography (ECG), electromyography (EMG), nerve conduction velocity (NCV, F wave, and H reflex), evoked potentials (EP, brainstem, visual, somatosensory), repetitive nerve stimulation and sleep assessment.

The Kilowin instrument is designed for use during the duration of the procedure only.

Use of the proposed device is to be administered under the direction of a2 trained physician, surgeon, neurologist, or electrophysiologist in an operating room or clinic.

The Kilowin device(s) are intended for use during efectroencephalography (EEG), electronystagmography (ENG), electromyography (EMG), nerve conduction velocity (NCV, F wave, and H reflex), evoked potentials (brainstem, visual, somatosensory), repetitive nerve stimulation testing and sleep assessment.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K971214: Kilowin.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K971214

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026